>A very marked focus on North America and near-shoring in Asia... - At the CMD, the group issued an update on its performance by region and reiterated its growth ambitions, notably in North America (c.10% of sales), driven by bolt-on acquisitions in environmental tests and connectivity, followed by pharma and cosmetics. In ASIA-Pacific (34% of sales), the group confirmed that it was maintaining strong momentum in China, a key market. The group is capitalising on an ad...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.